News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GNI Ltd. And Shanghai Genomics, Inc. Merge; Japanese And Chinese Biotech Companies Combine To Increase R&D Productivity And Market Opportunity



10/19/2005 5:09:13 PM

TOKYO & SHANGHAI, China--(BUSINESS WIRE)--June 20, 2005--GNI Ltd. and Shanghai Genomics announced today that the two companies have formed a merger. GNI concurrently raised a private equity round of financing of over $13M led by Nomura, Healthcare Partners and several other U.S. and Japanese private equity firms. The merger delivers several benefits, most notably from Shanghai Genomics' Western-quality discovery research, preclinical development, and contract research services to facilitate cost-efficient drug development, faster revenue generation and, ultimately, profitability for the united company.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES